Alnylam Pharmaceuticals, Inc. (ALNY) vs Roivant Sciences Ltd. (ROIV)

Alnylam Pharmaceuticals, Inc. and Roivant Sciences Ltd. are both Biotechnology companies. Alnylam Pharmaceuticals, Inc. is the larger, with a market value of $31.2B against $25.6B — 1.2× the size. Roivant Sciences Ltd. has negative trailing earnings, so its P/E is not meaningful; Alnylam Pharmaceuticals, Inc. trades at 43.6×. Alnylam Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 95.1% against −67.6%. Alnylam Pharmaceuticals, Inc. has the higher net margin (16.1% vs −3,535.0%) and the higher return on invested capital (0.00% vs −34.5%). Across the 18 metrics below, Alnylam Pharmaceuticals, Inc. leads on 14 and Roivant Sciences Ltd. on 4.